Concepedia

Author

Joseph W. Fay

Baylor University Medical Center

Also Known As

Comeau, Terrance, J Fay, J W Fay, J. Fay, J. W. Fay, J.W Fay, J.W. Fay, JOSEPH FAY, Jacob W. Fay, Joseph Fay

160

Publications

10.5K

Citations

52

H-Index

85

Concepts

All Affiliations

Baylor University Medical CenterBaylor UniversityFred Hutch Cancer CenterEmory UniversityTexas Oncology
JW

About

Joseph W. Fay is an author at Baylor University Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

32

3.5K

2

Health Sciences

11

12

577

3

Allergy

4

4

165

4

Public Health

1

1

646

5

Social Sciences

1

1

15

Joseph W. Fay

×

75

Publications

8.8K

Citations

44

H-Index

YearCitations

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Jacques Banchereau, A. Karolina Palucka, Madhav V. Dhodapkar,

PubMed

2001

813

A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus

Damien Chaussabel, Charles T. Quinn, Jing Shen,

Immunity

2008

646

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Richard A. Nash, Joseph H. Antin, Chatchada Karanes,

PubMed

2000

591

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka,

PubMed

1998

568

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Ajai Chari, Attaya Suvannasankha, Joseph W. Fay,

Blood

2017

438

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller,

Journal of Clinical Oncology

2013

437

Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo

Bali Pulendran, Jacques Banchereau, Susan Burkeholder,

The Journal of Immunology

2000

405

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

Karen H. Antman, Philip A. Rowlings, William P. Vaughan,

Journal of Clinical Oncology

1997

327

Autosomal recessive polycystic kidney disease

Bernard S. Kaplan, Joseph W. Fay, Vanita Shah,

Pediatric Nephrology

1989

248

Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity

A. Karolina Palucka, Hideki Ueno, John E. Connolly,

Journal of Immunotherapy

2006

231

Page 1